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ARTICLE
Altered structural brain asymmetry in autism
spectrum disorder in a study of 54 datasets
Merel C. Postema et al.#
Altered structural brain asymmetry in autism spectrum disorder (ASD) has been reported.
However, findings have been inconsistent, likely due to limited sample sizes. Here we
investigated 1,774 individuals with ASD and 1,809 controls, from 54 independent data sets of
the ENIGMA consortium. ASD was significantly associated with alterations of cortical
thickness asymmetry in mostly medial frontal, orbitofrontal, cingulate and inferior temporal
areas, and also with asymmetry of orbitofrontal surface area. These differences generally
involved reduced asymmetry in individuals with ASD compared to controls. Furthermore,
putamen volume asymmetry was significantly increased in ASD. The largest case-control
effect size was Cohen’s d=−0.13, for asymmetry of superior frontal cortical thickness. Most
effects did not depend on age, sex, IQ, severity or medication use. Altered lateralized neu-
rodevelopment may therefore be a feature of ASD, affecting widespread brain regions with
diverse functions. Large-scale analysis was necessary to quantify subtle alterations of brain
structural asymmetry in ASD.
https://doi.org/10.1038/s41467-019-13005-8 OPEN
#A full list of authors and their affiliations appears at the end of the paper.
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Autism spectrum disorder (ASD) is an umbrella diagnosis,capturing several previously separate pervasive develop-mental disorders with various levels of symptom severity,
including Autistic Disorder, Asperger’s Syndrome, Childhood
Disintegrative Disorder, and Pervasive Developmental Disorder—
Not Otherwise Specified (PDD-NOS)1. According to the Diag-
nostic and Statistical Manual of Mental Disorders (DSM) version
5, diagnosis of ASD requires the presence of at least three
symptoms of impaired social communication and at least two
symptoms of repetitive behaviors or restricted interests1. ASD has
a median prevalence of 1 out of 161 individuals in a study of
worldwide data2, with a higher diagnosis rate in some developed
countries such as the United States3.
Characterizing the neurobiology of ASD may eventually lead to
improved diagnosis and clinical subgrouping, and the develop-
ment of individually targeted treatment programs4. Although
much of the neurobiology of ASD remains unknown, subtle
alterations of brain structure appear to be involved (reviewed in
ref. 5,6). These include differences in total brain volume (children
with ASD have shown a larger average volume7–10), as well as
alterations of the medial and inferior frontal, anterior cingulate,
superior temporal, and orbitofrontal cortices, and the caudate
nucleus5,6,11. However, the results of structural magnetic reso-
nance imaging (MRI) studies of ASD have often been incon-
sistent, potentially owing to (1) small study sample sizes in
relation to subtle effects, (2) differences across studies in terms of
clinical characteristics, age, comorbidity, and medication use, (3)
methodological differences between studies, such as differences in
hardware, software, and distinct data processing pipelines12, and
(4) the etiological and neurobiological heterogeneity of ASD,
which exists as a group of different syndromes rather than a
single entity13.
In the ENIGMA (Enhancing Neuro-Imaging Genetics through
Meta-Analysis) consortium (http://enigma.ini.usc.edu), research-
ers from around the world collaborate to analyze many separate
data sets jointly, and to reduce some of the technical heterogeneity
by using harmonized protocols for MRI data processing. A recent
study by the ENIGMA consortium’s ASD working group showed
small average differences in bilateral cortical and subcortical brain
measures between 1571 cases and 1650 healthy controls, in the
largest study of brain structure in ASD yet performed14. Relative
to controls, ASD patients had significantly lower volumes of
several subcortical structures, as well as greater thickness in var-
ious cortical regions—mostly in the frontal lobes—and lower
thickness of temporal regions. No associations of diagnosis with
regional cortical surface areas were found14.
Left–right asymmetry is an important aspect of human brain
organization, which may be altered in various psychiatric and
neurocognitive conditions, including schizophrenia, dyslexia, and
ASD15–17. On a functional level, people with ASD demonstrate
reduced leftward language lateralization more frequently than
controls18–20. Resting-state functional MRI data of people with
ASD have also shown a generally rightward shift of asymmetry
involving various functional networks of brain regions21. In
addition, people with ASD have a higher rate of left-handedness
than the general population20,22,23. Furthermore, an electro-
encephalography study reported that infants at high risk for ASD
showed more rightward than leftward frontal alpha asymmetry at
rest24.
Brain structural imaging studies have also reported altered
hemispheric asymmetry in ASD. Diffusion imaging studies
indicated reduced asymmetry of a variety of different white
matter tract metrics25–27, although in one study males with ASD
lacked an age-dependent decrease in rightward asymmetry of
network global efficiency, compared with controls28. A structural
MRI study investigating gray matter reported lower leftward
volume asymmetry of language-related cortical regions in ASD
(i.e., planum temporale, Heschl’s gyrus, posterior supramarginal
gyrus, and parietal operculum), as well as greater rightward
asymmetry of the inferior parietal lobule29. The volume and
surface area of the fusiform gyrus also showed lower rightward
asymmetry in ASD30. However, other studies did not find
alterations of gray matter asymmetries in ASD27,31.
Prior studies of structural brain asymmetry in ASD had
sample sizes less than 128 cases and 127 controls. The previous
ENIGMA consortium study of ASD14 did not perform analyses
of brain asymmetry, but reported bilateral effects only as strong
as Cohen’s d=−0.21 (for entorhinal thickness bilaterally)14.
Comparable bilateral effect sizes were also found in ENIGMA
consortium studies of other disorders14,32–38. If effects on brain
asymmetry are similarly subtle, then prior studies of this aspect
of brain structure in ASD were likely underpowered. Low power
not only reduces the chance of detecting true effects, but also the
likelihood that a statistically significant result reflects a true
effect39,40. Therefore large-scale analysis is needed to determine
whether, and how, structural brain asymmetry might be altered
in ASD, to better describe the neurobiology of the condition.
Here, we made use of MRI data from 54 data sets that were
collected across the world by members of the ENIGMA con-
sortium’s ASD Working Group, to perform the first highly
powered study of structural brain asymmetry in ASD. Using a
single, harmonized protocol for image analysis, we derived
asymmetry indexes, AI= (Left−Right)/(Left+ Right), for multi-
ple brain regional and global hemispheric measures, in up to 1778
individuals with ASD and 1829 typically developing controls. The
AI is a widely used index in brain asymmetry studies41,42.
Age and sex are known to affect cortical-43 as well as sub-
cortical asymmetries44 in healthy individuals. In addition, a
recent structural imaging study of roughly 500 individuals with
ASD, and 800 controls, found that case–control differences of
bilateral cortical thickness were greater in younger versus older
individuals, whereas also being related to ASD symptom severity,
and with larger differences in individuals with lower versus higher
full-scale intelligent quotient (IQ) scores45. Other previous
case–control MRI findings with respect to these indicators of
clinical heterogeneity in ASD are also reviewed in that paper45. In
the present study, we therefore carried out secondary analyses in
which we tested brain asymmetries in relation to age- or sex-
specific effects, IQ, and disorder severity. We also included an
exploratory analysis of medication use.
Results
Significant associations of ASD with brain asymmetry. Sum-
mary information for the data sets is in Table 1. Out of a total of
78 structural AIs that were investigated (Supplementary
Tables 1–3), 10 showed a significant effect of diagnosis, which
survived multiple testing correction (Table 2). Among these were
seven regional cortical thickness AIs, including frontal regions
(superior frontal, rostral middle frontal, medial orbitofrontal),
temporal regions (fusiform, inferior temporal), and cingulate
regions (rostral anterior, isthmus cingulate). Two cortical
regional surface area AIs, namely of the medial- and lateral
orbitofrontal cortex, were significantly associated with diagnosis
(medial: β= 0.006, t= 3.2, P= 0.0015; lateral: β=−0.005, t=
−3.3, P= 0.0010) (Table 2, Supplementary Table 2), as well as
one subcortical volume AI, namely that of the putamen (β=
0.00395, t= 3.4, P= 0.00069) (Table 2, Supplementary Table 3).
Nominally significant effects of diagnosis on AIs (i.e., with P <
0.05, but which did not survive multiple comparison correction),
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were observed for the fusiform surface area AI (β=−0.005, t=
−2.56, P= 0.010) (Supplementary Table 2), pars orbitalis
thickness AI (β=−0.003, t=−2.26, P= 0.024), posterior
cingulate thickness AI (β=−0.003, t=−2.1, P= 0.034), super-
ior temporal thickness (β=−0.002, t=−1.97, P= 0.049), and
caudate nucleus volume (β= 0.003, t= 2.24, P= 0.025).
Sensitivity analyses. When we repeated the analysis after win-
sorizing outliers, the pattern of results remained the same (Sup-
plementary Tables 4–6), except that a small change in P value for
the effect of diagnosis on medial orbitofrontal surface area AI
meant that it no longer survived false discovery rate (FDR) cor-
rection (Supplementary Table 5).
Table 1 Characteristics of the different data sets of the ENIGMA ASD working group
Sample name N total N cases (M/F) N controls (M/F) Median age in years (range) Scanner type Field strength
ABIDE_CALTECH 31 13/1 13/4 23.4 (17.5, 56.2) Siemens Trio 3 T
ABIDE_KKI 21 7/0 11/3 10.6 (8.4, 12.8) Philips Achieva 3 T
ABIDE_LEUVEN_1 29 14/0 15/0 22 (18, 32) Philips Interna 3 T
ABIDE_LEUVEN_2 35 12/3 15/5 14.2 (12.1, 16.9) Philips Interna 3 T
ABIDE_MAX_MUN 57 21/3 29/4 26 (7, 58) Siemens Verio 3 T
ABIDE_NYU 186 68/11 81/26 13.6 (6.5, 39.1) Siemens Allegra 3 T
ABIDE_OHSU 18 7/0 11/0 10 (8.2, 12.7) Siemens Trio 3 T
ABIDE_OLIN 36 17/3 14/2 17 (10, 24) Siemens Allegra 3 T
ABIDE_PITT 58 26/5 23/4 17 (9.3, 35.2) Siemens Allegra 3 T
ABIDE_SBL 30 15/0 15/0 33.5 (20, 64) Philips Interna 3 T
ABIDE_SDSU 37 14/1 16/6 14.8 (8.7, 37.7) GE MR750 3 T
ABIDE_STANFORD 40 16/4 16/4 9.4 (7.5, 12.9) GR Signa 3 T
ABIDE_TCD 55 24/1 30/0 15.9 (9.3, 25.9) Philips Achieva 3 T
ABIDE_UM_1 130 50/14 43/23 12.3 (8.1, 20.9) GE Signa 3 T
ABIDE_UM_2 31 14/1 15/1 14.8 (11.1, 26.8) GE Signa 3 T
ABIDE_USM 101 59/0 42/0 19.6 (8.2, 50.2) Siemens Trio 3 T
ABIDE_YALE 55 20/8 19/8 12.8 (7, 17.8) Siemens Magnetom 3 T
ABIDEII-BNI 58 29/0 29/0 43 (18, 64) Philips Ingenia 3 T
ABIDEII-EMC 54 22/5 22/5 8.2 (6.2, 10.7) GE MR750 3 T
ABIDEII-ETH 37 13/0 24/0 22.3 (13.8, 30.7) Philips Achieva 3 T
ABIDEII-GU 106 43/8 28/27 10.6 (8.1, 13.9) Siemens TriTim 3 T
ABIDEII-IP 56 14/8 12/22 18.4 (6.1, 46.6) Siemens TriTim 1.5 T
ABIDEII-IU 40 16/4 15/5 22 (17, 54) Philips Achieva 3 T
ABIDEII-KKI 211 41/15 99/56 10.3 (8, 13) Philips Achieva 3 T
ABIDEII-KUL* 28 28/0 – 24 (18, 35) Philips Achieva 3 T
ABIDEII-NYU_1 78 43/5 28/2 8.4 (5.2, 34.8) Siemens Allegra 3 T
ABIDEII-NYU_2* 27 24/3 – 7 (5.1, 8.8) Siemens Allegra 3 T
ABIDEII-OHSU 93 30/7 27/29 11 (7, 15) Siemens Skyra 3 T
ABIDEII-OILH 59 20/4 20/15 23 (18, 31) Siemens TriTim 3 T
ABIDEII-SDSU 57 26/7 22/2 13 (7.4, 18) GE MR750 3 T
ABIDEII-TCD 43 21/0 22/0 14.8 (10, 20) Philips Achieva 3 T
ABIDEII-UCD 32 14/4 10/4 14.6 (12, 17.8) Siemens TriTim 3 T
ABIDEII-UCLA 32 15/1 11/5 9.6 (7.8, 15) Siemens TriTim 3 T
ABIDEII-USM 33 15/2 13/3 19.7 (9.1, 38.9) Siemens TriTim 3 T
Barcelona 76 39/4 32/1 12.3 (7.2, 17.1) Siemens Trio 3 T
BRC 52 19/0 33/0 15 (10, 18) GE Signa HDx 3 T
CMU 27 11/3 10/3 27 (19, 40) Siemens Magnetom 3 T
Dresden 45 18/3 20/4 31.2 (21.1, 56.8) Siemens Trio 3 T
FAIR 85 36/7 27/15 11.6 (7.2, 15.9) Siemens Magnetom 3 T
FRANKFURT 27 10/2 13/2 18 (18, 18) Siemens Sonata 1.5 T
FSM 80 20/20 20/20 4.1 (1.8, 6) GE Signa 1.5 T
MRC 148 74/0 74/0 25 (18, 45) GE Signa HDx 3 T
MYAD 73 59/0 14/0 4.5 (1.5, 9) Siemens symphony 1.5 T
NIJMEGEN1_1 33 14/3 14/2 15.1 (12.3, 18) Siemens Trio 3 T
NIJMEGEN1_2* 9 – 8/1 17.5 (13.4, 18.5) Siemens Trio 3 T
NIJMEGEN2 72 29/19 16/8 26 (18, 40) Siemens Avanto 1.5 T
NIJMEGEN3 95 37/4 45/9 9.7 (6.1, 12.3) Siemens Avanto 1.5 T
ParelladaHGGM 66 33/2 30/1 13 (7, 18) Philips Intera 1.5 T
PITT_1 56 11/3 34/8 15 (8, 36) Siemens Allegra 3 T
PITT_2 90 39/6 39/6 15 (8, 36) Siemens Allegra 3 T
SAOPAULO 35 15/0 20/0 11 (6, 19) Philps 3 T
TCD_1 50 28/0 22/0 14.9 (10, 21.8) Philips Achieva 3 T
TCD_2 39 17/0 22/0 15.9 (12, 25.9) Philips Achieva 3 T
TORONTO_1 219 82/23 57/57 11.9 (3.3, 20.8) Siemens Trio 3 T
TORONTO_2 203 107/43 29/24 11 (2.5, 21.7) Siemens Trio 3 T
UMCU_1 88 41/7 37/3 12.1 (7.1, 24.7) Philips 1.5 T
UMCU_2 9 6/0 2/1 11.8 (10, 12.6) Philips 1.5 T
Total 3671 1833 1838
*Excluded, as diagnosis would be completely confounded with random variable ‘data set’ in the analysis model. For the calculation of the totals (in bold) these data sets were also excluded
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When we added a non-linear effect for age, all of the 10 AIs
that had shown significant effects of diagnosis in the primary
analysis remained significant (Supplementary Tables 4–6).
When we excluded all individuals below 6 years of age, that
may have been more difficult for FreeSurfer to segment, all AIs
that had shown significant effects of diagnosis in the primary
analysis remained significant, except for the isthmus cingulate
thickness AI (Supplementary Tables 4–6). In addition, one new
association with diagnosis, of the fusiform surface area AI, now
surpassed the multiple testing correction threshold. These subtle
changes of P values do not necessarily indicate that exclusion of
younger ages improved signal to noise in the data.
When excluding all individuals aged 40 years or older, the
pattern of significant results stayed the same (Supplementary
Tables 4–6).
Finally, when analyzing only the subset of 3T-acquired data,
two of the diagnosis effects from the primary analysis (i.e.,
inferior temporal- and isthmus cingulate thickness AI) were no
longer significant after false discovery rate correction, but three
other effects now became significant (i.e., superior temporal
thickness AI, fusiform surface area AI, and caudate nucleus AI)
(Supplementary Tables 4–6). Again, slight changes in significance
levels are expected when changing the sample, and do not
necessarily indicate systematic differences of 3 T and 1.5 T data
with respect to case–control asymmetry differences.
Magnitudes and directions of asymmetry changes. Cohen’s d
effect sizes of the associations between AIs and diagnosis, as
derived from the primary analysis, are visualized in Fig. 1. Effect
sizes were low, ranging from −0.13 (superior frontal thickness
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c
Fig. 1 Cohen’s d effect sizes of the associations between diagnosis and
AIs. a regional cortical thickness measures, b cortical surface areas,
c subcortical volumes. Values are overlaid on left hemisphere inflated
brains. Positive Cohen’s d values (yellow) indicate mean shifts towards
greater leftward or reduced rightward asymmetry in cases, and negative
Cohen’s d values (blue) indicate mean shifts towards greater rightward
asymmetry or reduced leftward asymmetry in individuals with ASD
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AI) to 0.12 (Putamen AI) (Table 2, Supplementary Tables 1–3).
All of the cortical AIs with significant effects of diagnosis in the
primary analysis showed decreased asymmetry in ASD compared
with controls, i.e., the AIs were closer to zero in individuals with
ASD than in controls, regardless of whether the region was on
average leftward or rightward asymmetrical in controls (Table 3).
However, the putamen showed increased asymmetry in ASD
(mean AI controls= 0.011, mean AI cases= 0.012) (Table 3).
Five of the seven significant changes in regional cortical
thickness asymmetry involved left-sided decreases accompanied
by right-sided increases of thickness (Table 3). For the other two
significant effects on regional thickness asymmetry (the fusiform
and inferior temporal cortex), thickness was decreased bilaterally
in ASD, but more so in the right than the left hemisphere. For the
significant changes in surface area asymmetry (lateral orbito-
frontal and medial orbitofrontal cortex), surface area was altered
in opposite directions in ASD in the two hemispheres, thus
resulting in altered asymmetry (Table 3). Finally, the putamen
showed a bilateral decrease in volume in ASD that was more
pronounced on the right, resulting in altered asymmetry
(Table 3).
Age or sex interaction effects. The distributions of age and
sex across all data sets are plotted in Supplementary Fig. 1. In
secondary analysis of interaction effects, there was only one sig-
nificant sex:diagnosis interaction effect after FDR correction, for
the rostral anterior cingulate thickness AI (Supplementary
Tables 7–9). This AI had shown a significant effect of diagnosis in
the primary analysis. In analysis within the sexes separately, this
AI was associated with diagnosis in males (P= 1.4 × 10–5) but not
females (p= 0.165) (Supplementary Table 7). For all of the AIs,
which showed significant effects of diagnosis in the primary
analysis, adding sex:diagnosis interaction terms did not change
the pattern of significant main effects of diagnosis, after FDR
correction (Supplementary Tables 7–9).
There were no significant age:diagnosis interaction effects after
FDR correction (Supplementary Tables 10–12). In general, for
AIs which showed significant effects of diagnosis in the primary
analysis, adding age:diagnosis interaction terms largely reduced
the significance of the main effects of diagnosis, even though the
age:diagnosis interaction terms were not significant (all P > 0.05)
(Supplementary Tables 10–12). However, adding these interac-
tion terms also increased the AIC and BIC scores compared with
the primary analysis models without these terms, indicating
poorer model fit when including these non-significant interaction
terms (Supplementary Tables 10–12).
Exploratory analysis of IQ. The distributions of IQ within
individuals with ASD and controls are shown in Supplemen-
tary Fig. 2. Out of the 10 AIs that showed significant case–control
differences in the primary analysis, only one showed an asso-
ciation with IQ within individuals with ASD (uncorrected P <
0.05; Supplementary Table 13). This was the rostral anterior
cingulate thickness AI (β= 0.00019, t= 2.49, p= 0.013). The
positive direction of this effect indicates that primarily those ASD
individuals with lower IQ show reduced leftward asymmetry of
the rostral anterior cingulate thickness. This regional asymmetry
had also shown a significant sex*diagnosis interaction (see above).
For this specific regional AI, we therefore added age:IQ, sex:IQ
and age:sex:IQ interactions to the model, but none of these terms
were significant (all uncorrected P > 0.05).
Within controls, only the superior frontal thickness AI was
associated with IQ at uncorrected P < 0.05 (Supplementary
Table 13) (β=−0.00012, t=−3.41, p= 0.001).This effect
suggests that controls with lower IQ show relatively increased T
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asymmetry of superior frontal thickness, although this was post
hoc, exploratory analysis without multiple testing correction.
Analysis of autism diagnostic observation schedule (ADOS)
severity scores. The distributions of ADOS severity scores are
plotted in Supplementary Fig. 2. Out of the AIs that showed
significant case–control differences in the primary analysis, only
the isthmus cingulate thickness AI showed an association
(uncorrected P < 0.05) with the ADOS severity score (β= 0.0041,
t= 2.6, p= 0.011) (Supplementary Table 14). The positive
direction of the effect suggests that primarily cases with low ASD
severity have reduced leftward asymmetry of this regional
thickness.
Medication use. We found no significant effects of medication
use (all uncorrected P > 0.05) (Supplementary Table 15).
Discussion
In this, the largest study to date of brain asymmetry in ASD, we
mapped differences in brain asymmetry between participants
with ASD and controls, in a collection of 54 international data
sets via the ENIGMA Consortium. We had 80% statistical power
to detect Cohen’s d effect sizes in the range of 0.12–0.13. We
found significantly altered asymmetries of seven regional cortical
thickness asymmetries in ASD compared with controls, pre-
dominantly involving medial frontal, orbitofrontal, inferior tem-
poral, and cingulate regions. The magnitude of all regional
thickness asymmetries was decreased in ASD compared with
controls, whether it was reduced leftward, reduced rightward, or
reversed average asymmetry. Rightward asymmetry of the medial
orbitofrontal surface area was also decreased in individuals with
ASD, as was leftward asymmetry of the lateral orbitofrontal
surface area. In addition, individuals with ASD showed an
increase in leftward asymmetry of putamen volume, compared
with controls.
Previous MRI studies of cerebral cortical asymmetries in ASD,
based on much smaller data sets, and using diverse methods for
image analysis, suggested variable case–control differences29,30, or
no differences27,31. Our findings partly support a previously
reported, generalized reduction of leftward asymmetry29, as six of
the nine significantly altered cortical regional asymmetries
(thickness or surface area) involved decreased leftward asym-
metries. However, three of the nine significantly altered cortical
regional asymmetries involved shifts leftwards in ASD, either
driven by a more prominent increase on the left side in ASD (i.e.,
medial orbitofrontal surface area), or by more prominent right-
than left-side decreases in ASD (i.e., fusiform- and inferior tem-
poral thickness). Thus, the directional change of asymmetry can
depend on the specific region, albeit that the overall magnitude of
asymmetry is most likely to be reduced in ASD.
The significant associations of diagnosis with asymmetry in the
present study were all weak (Cohen’s d=−0.13–0.12), indicating
that altered structural brain asymmetry is unlikely to be a useful
predictor for ASD. Prior studies using smaller samples were
underpowered in this context. However, the effect sizes were
comparable to those reported by recent, large-scale studies of
bilateral disorder-related changes in brain structure, in which
asymmetry was not studied, including for ASD14 as well as
attention-deficit hyperactivity disorder (ADHD)38,46, schizo-
phrenia37, obsessive compulsive disorder (OCD)32,33, posttrau-
matic stress disorder34, and major depressive disorder35,36. It has
become increasingly clear that anatomical differences between
ASD and control groups are very small relative to the large
within-group variability that is observed47.
Our findings may inform understanding of the neurobiology of
ASD. Multi-regional reduction of cortical thickness asymmetry in
ASD fits with the concept that laterality is an important orga-
nizing feature of the healthy human brain for multiple aspects of
complex cognition, and is susceptible to disruption in disorders
(e.g., 16,48). Left–right asymmetry facilitates the development of
localized and specialized modules in the brain, which can then
have dominant control of behavior49,50. Notably, some of the
cortical regions highlighted here are involved in diverse social
cognitive processes, including perceptual processing (fusiform
gyri), cognitive and emotional control (anterior cingulate), and
reward evaluation (orbitofrontal cortex, ventral striatum)51.
However, the roles of these brain structures are by no means
restricted to social behavior. As we found altered asymmetry of
various additional regions, our findings suggest broader disrup-
tion of lateralized neurodevelopment as part of the ASD pheno-
type. We note that many of the regions that showed significant
case–control differences in asymmetry, including medial frontal,
anterior cingulate, and inferior temporal regions, overlap with the
default mode network (DMN). The DMN comprises various
cortical regions located in temporal (medial and lateral), parietal
(medial and lateral) and prefrontal (medial) cortices52. DMN
network organization has shown evidence for differences in
ASD11,53–55, including alterations in functional laterality56. Our
findings may therefore further support a role of altered later-
alization of the DMN in ASD, warranting further investigations
in this direction.
The medial orbitofrontal cortex was the only region that
showed significantly altered asymmetry of both thickness and
surface area in ASD, suggesting that disrupted laterality of this
region might be particularly important in ASD. The orbitofrontal
cortex may be involved in repetitive and stereotyped behaviors in
ASD, owing to its roles in executive functions57. Prior studies
have reported lower cortical thickness in the left medial orbito-
frontal gyrus in ASD58, altered patterning of gyri and sulci in the
right orbitofrontal cortex59, and altered asymmetry in frontal
regions globally25,31. These studies were in much smaller sample
sizes than used here.
As regards the fusiform cortex, a previous study by Dougherty
et al.30 reported an association between higher ASD symptom
severity and increased rightward surface area asymmetry, but not
thickness asymmetry. The fusiform gyrus is involved in facial
perception and memory among other functions, which are
important for social interactions60. Here we report an asymmetry
change in fusiform thickness in ASD that was significant after
multiple testing correction, but there was also a nominally sig-
nificant rightward change of surface area asymmetry in ASD (i.e.,
that did not survive multiple testing correction). This underlines
that separate analyses of regional cortical thickness and surface
area are well motivated, as they can vary relatively
independently61.
The altered volume asymmetry of the putamen in ASD may be
related to its role in repetitive and restricted behaviors in ASD.
One study reported that differences in striatal growth trajectories
were correlated with circumscribed interests and insistence on
sameness62. The striatum is connected with lateral and orbito-
frontal regions of the cortex via lateral–frontal–striatal reward
and top-down cognitive control circuitry that might be dys-
functional in ASD63. For example, individuals with ASD have
shown decreased activation of the ventral striatum and lateral
inferior/orbitofrontal cortex during outcome anticipation, and of
dorsal striatum and lateral–frontal regions during sustained
attention and inhibitory control, compared with typically devel-
oping controls11,55,63.
Although the reasons for asymmetrical alterations in many of
the structures implicated here are unclear, our findings suggest
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altered neurodevelopment affecting these structures in ASD.
Further research is necessary to clarify the functional relevance
and relationships between altered asymmetry and ASD. The
findings we report in this large–scale study sometimes did not
concur with prior, smaller studies. This may be owing to limited
statistical power in the earlier studies, whereas low power reduces
the likelihood that a statistically significant result reflects a true
effect40. However, the cortical atlas that we used did not have
perfect equivalents for regions defined in many of the earlier
studies, and we did not consider gyral/sulcal patterns, or gray
matter volumes as such. Furthermore, discrepancies with earlier
studies may be related to age differences, and differences in
clinical features of the disorder arising from case recruitment and
diagnosis.
We included subjects from the entire ASD severity spectrum,
with a broad range of ages, IQs, and of both sexes. Only one effect
of diagnosis on regional asymmetry was influenced by sex, i.e., the
rostral anterior cingulate thickness asymmetry, which was altered
in males but not in females. This same regional asymmetry was
primarily altered in lower versus higher IQ cases. This may
therefore be an alteration of cortical asymmetry that is relatively
specific to an ASD subgroup, i.e., lower-performing males. In
controls, a different asymmetry (i.e., superior frontal thickness
AI) showed a nominally significant association with IQ, which
may point to different brain-IQ associations in ASD and controls.
However, we cannot make strong interpretations based on these
exploratory, secondary analyses without multiple testing
correction.
As regards symptom severity, thickness asymmetry of the
isthmus of the cingulate was associated with the ADOS score,
such that the lower severity cases tended to have the most altered
asymmetry. Again, this post hoc finding remains tentative in the
context of multiple testing, and is reported here for descriptive
purposes only. It is clear that most of the AIs that showed sig-
nificant changes in ASD were not correlated with ADOS scores.
We found no evidence that medication use affected any of the
asymmetries altered in ASD, although our medication variable
was rudimentary. The role of specific medication usage should be
investigated in future studies. As mentioned above, data on
comorbidities were only available for 54 of the ASD subjects,
precluding a high-powered analysis of this issue. This is a lim-
itation of the study. We did not analyze handedness in the present
study, as this had no significant effect on the same brain asym-
metry measures as analyzed here, in studies of healthy individuals
comprising more than 15,000 participants43,44.
In contrast to some prior studies of ASD, we did not adjust for
IQ as a covariate effect in our main, case–control analysis. Rather,
we carried out post hoc analysis of possible associations between
IQ and brain asymmetries, separately in cases and controls. This
was because lower average IQ was clearly part of the ASD phe-
notype in our total combined data set (Supplementary Fig. 1D),
so that including IQ as a confounding factor in case–control
analysis might have reduced the power to detect an association of
diagnosis with asymmetry. This would occur if underlying sus-
ceptibility factors contribute both to altered asymmetry and
reduced IQ, as part of the ASD phenotype.
The Desikan–Killiany atlas64 was derived from manual seg-
mentations of sets of reference brain images. Accordingly, the
mean regional asymmetries in our samples partly reflect left–right
differences present in the reference data set used to construct the
atlas. For detecting cerebral asymmetries with automated meth-
ods, some groups have chosen to work from artificially created,
left–right symmetrical atlases, e.g., ref. 65. However, our study was
focused on comparing relative asymmetry between groups. The
use of a ‘real-world’ asymmetrical atlas had the advantage that
regional identification was likely to be more accurate for
structures that are asymmetrical both in the atlas and, on average,
in our data sets. By defining the regions of interest in each
hemisphere based on each hemisphere’s own particular features,
such as its sulcal and gyral geometry, we could then obtain the
corresponding relationships between hemispheres. To this end,
we used data from the automated labeling program within
FreeSurfer for subdividing the human cerebral cortex. The
labeling system incorporates hemisphere-specific information on
sulcal and gyral geometry with spatial information regarding the
locations of brain structures, and shows a high accuracy when
compared with manual labeling results64. Thus, reliable measures
of each region can be extracted for each subject, and regional
asymmetries then accurately assessed.
Although a single image analysis pipeline was applied to all
data sets, heterogeneity of imaging protocols was a feature of this
study. There were substantial differences between data sets in the
average asymmetry measured for some regions, which may be
owing in part to different scanner characteristics, as well as dif-
ferences in patient profiles. We corrected for ‘data set’ as a ran-
dom effect in the analysis, and sensitivity analysis based on the
subset of 3 T acquired data showed similar results to the primary
analysis. However, it is possible that between-data set variability
resulted in reduced statistical power, relative to a hypothetical,
equally sized, single-center study. In reality, no single centre has
been able to collect such large samples alone. As long as
researchers publish many separate papers based on single data
sets, collected in particular ways, the field overall has the same
problem. In this case, multi-centre studies can better represent
the real-world heterogeneity, with more generalizable findings
than single-centre studies66. The primary purpose of our study,
based on 54 data sets that were originally collected as separate
studies, was to assess the total combined evidence for effects over
all of these data sets, whereas allowing for heterogeneity between
data sets through the use of random intercepts, and finally adding
sensitivity and secondary analyses with respect to relevant
variables.
The cross-sectional design limits our capacity to make causal
inferences between diagnosis and asymmetry. ASD is highly
heritable, with meta-analytic heritability estimates ranging from
64 to 91%67. Likewise, some of the brain asymmetry measures
examined here have heritabilities as high as roughly 25%43,44.
Future studies are required to investigate shared genetic con-
tributions to ASD and variation in brain structural asymmetry.
These could help to disentangle cause-effect relations between
ASD and brain structural asymmetry. Given the high comorbidity
of ASD with other disorders, such as ADHD, OCD, and schi-
zophrenia68, cross-disorder analyses incorporating between-
disorder genetic correlations may be informative.
In conclusion, large-scale analysis of brain asymmetry in ASD
revealed primarily cortical thickness effects, but also effects on
orbitofrontal cortex asymmetry, and putamen asymmetry, which
were significant but very small. Our study illustrates how high-
powered and systematic studies can yield much needed clarity in
human clinical neuroscience, where prior smaller and more
methodologically diverse studies were inconclusive.
Methods
Data sets. Structural MRI data were available for 57 different data sets (Table 1).
Three data sets comprising either cases only, or controls only, were removed in this
study (Table 1), as our analysis model included random intercepts for ‘data set’
(below), and diagnosis was fully confounded with data set for these three. The
remaining 54 data sets comprised 1778 people with ASD (N= 1504 males; median
age= 13 years; range= 2–64 years) and 1829 typically developing controls (N=
1400 males; median age= 13 years; range= 2–64 years).
All data sets were collected during the period when DSM-IV and DSM-IV-TR
were the common classification systems, between 1994 and 2013, and the clinical
diagnosis of ASD was made according to DSM-IV criteria69. The data sets were
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collected in a variety of different countries, and intended originally as separate
studies. Nonetheless, all subjects were diagnosed based on clinical diagnosis by a
clinically experienced and board certified physician/psychiatrist/psychologist. This
was a criterion for admission of a data set into the ENIGMA-ASD database. For
each of the 54 data sets, all relevant ethical regulations were complied with, and
appropriate informed consent was obtained for all individuals.
Total scores from the Autism Diagnostic Observation Schedule-Generic
(ADOS), a standardized instrument commonly used in autism diagnosis70, were
available for a majority of cases (N= 878). Cases from the entire ASD spectrum
were included, but only 66 cases had IQ below 70 (cases: mean IQ= 104, SD= 19,
min= 34, max= 149; see Supplementary Fig. 1D). The presence/absence of
comorbid conditions had been recorded for 519 of the cases, but only 54 cases
showed at least one comorbid condition (which could be ADHD, OCD, depression,
anxiety, and/or Tourette’s syndrome14). Numbers related to DSM-IV subtypes of
ASD were not collated by the ENIGMA ASD working group, as this subtyping
scheme has been dropped from DSM-V due to low reliability71.
There was not a homogeneous assessment/recruitment process for controls
across the 54 data sets, but the overwhelming majority were typically developing/
healthy at the time of MRI, and no controls showed features that might have met
criteria for a diagnosis of ASD. Only 19 controls had IQ > 70. In these subjects the
exclusion of ASD diagnosis was performed by a senior child psychiatrist/physician.
Eighteen of these were from the FSM data set and were clinically diagnosed with
idiopathic intellectual disability. Amongst all controls the mean IQ was 112, SD=
15, min= 31, max= 149; see Supplementary Fig. 1D.
Structural MRI. Structural T1-weighted brain MRI scans were acquired at each
study site. As shown in Table 1, images were acquired using different field strengths
(1.5 T or 3 T) and scanner types. Each site used harmonized protocols from the
ENIGMA consortium (http://enigma.ini.usc.edu/protocols/imaging-protocols) for
data processing and quality control. The data used in the current study were
thickness and surface area measures for each of 34 bilaterally paired cortical
regions, as defined with the Desikan–Killiany atlas64, as well as the average cortical
thickness and total surface area per entire hemisphere. In addition, left and right
volumes of seven bilaterally paired subcortical structures, plus the lateral ventricles,
were analyzed. Cortical parcellations and subcortical segmentations were per-
formed with the freely available and validated software FreeSurfer (versions 5.1 or
5.3)72, using the default ‘recon-all’ pipeline, which also incorporates renormaliza-
tion. Parcellations of cortical grey matter regions and segmentations of subcortical
structures were visually inspected following the standardized ENIGMA quality
control protocol ((http://enigma.ini.usc.edu/protocols/imaging-protocols). Exclu-
sions on the basis of this quality control resulted in the sample sizes mentioned
above (see Data sets). In briefy, cortical segmentations were overlayed on the T1
image of each subject. Web pages were generated with snapshots from internal
slices, as well as external views of the segmentation from different angles. All sites
were provided with the manual on how to judge these images, including the most
common segmentation errors. For subcortical structures, the protocol again con-
sisted of visually checking the individual images, plotted from a set of internal
slices. Volume estimates derived from poorly segmented structures (i.e., where
tissue labels were assigned incorrectly) were excluded from each site’s data sets and
subsequent analyses. In addition, any data points exceeding 1.5 times the inter-
quartile range, as defined per site and diagnostic group, were visually inspected
(3D). When identified as error, all values from the affected regions were excluded
from further analysis.
Asymmetry measures. Separately for each structural measure and individual
subject, left (L) and right (R) data were used in R (version 3.5.3) to calculate
an asymmetry index (AI) with the following formula: AI= (L − R)/(L + R).
Distributions of each of the AIs are plotted in Supplementary Fig. 2. Note that
AIs do not necessarily scale with L, R, or brain size, owing to their denominators.
Linear mixed effects random-intercept model mega-analysis. Model: linear
mixed effects models were fitted separately for each cortical regional surface and
thickness AI, as well as the total hemispheric surface area and mean thickness AI,
and the subcortical volume AIs. This was accomplished by means of mega-analysis
incorporating data from all 54 data sets, using the ‘nlme’ package in R73. All models
included the same fixed- and random effects, and had the following formulation:
AI ¼ diagnosis þ ageþ sexþ randomð¼ datasetÞ
where AI reflects the AI of a given brain structure, and diagnosis (‘controls’ (=
reference), ‘ASD’), sex (‘males’ (= reference), ‘females’) and data setwere coded as
factor variables, with data set having 54 different categories. Age was coded as a
numeric variable.
The Maximum Likelihood method was used to fit the models. Subjects were
omitted if data were missing for any of the predictor variables (method= na.omit).
The ggplot2 package in R was used to visualize residuals (Supplementary Figs. 3–5).
Collinearity of predictor variables was assessed using the ‘usdm’ package in R
(version 3.5.3.).
Significance. Significance was assessed based on the P values for the effects of
diagnosis on AIs. The FDR74 was estimated separately for the 35 cortical surface
area AIs (i.e., 34 regional AIs and one hemispheric total AI) and the 35 cortical
thickness AIs, and again for the seven subcortical structures plus lateral ventricles,
each time with a FDR threshold of 0.05. Correlations between AI measures were
calculated using Pearson’s R and visualized using the ‘corrplot’ package in R
(Supplementary Figs. 6–8). Most pairwise correlations between AIs were low, with
only 33/78 pairwise correlations either lower than − 0.3 or > 0.3, with a minimum
R=−0.351 between the inferior parietal surface area AI and supramarginal surface
area AI, and maximum R= 0.487 between the cuneus surface area AI and peri-
calcarine surface area AI.
Cohen’s d effect sizes. The t-statistic for the factor ‘diagnosis’ in each linear
mixed effects model was used to calculate Cohen’s d75, with
d ¼ t  ðn1þ n2Þffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðn1  n2Þp  ffiffiffiffiffidfp ð1Þ
where n1 and n2 are the number of cases and controls, and df the degrees of
freedom.
The latter was derived from the lme summary table in R, but can also be
calculated using df= obs − (x1 + x2), where obs equals the number of
observations, x1 the number of groups and x2 the number of factors in the model.
The 95% confidence intervals for Cohen’s d were calculated using 95% CI= d ±
1.96 SE, with the standard error (SE) around Cohen’s d calculated according to:
SE ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
n1þ n2
n1  n2 þ
d2
2  ðn1þ n2 2Þ
s
ð2Þ
For visualization of cerebral cortical results, Cohen’s d values were loaded into
Matlab (version R2016a), and 3D images of left hemisphere inflated cortical and
subcortical structures were obtained using FreeSurfer-derived ply files.
Power analyses. As each linear model included multiple predictor variables, the
power to detect an effect of diagnosis on AI could not be computed exactly, but we
obtained an indication of the effect size that would be needed to provide 80%
power, had we been using simple t tests and Bonferroni correction for multiple
testing, using the ‘pwr’ command in R. For this purpose, a significance level of
0.0014 (i.e., 0.05/35) was set in the context of multiple testing over the regional and
total cortical surface area AIs (N= 35) or thickness AIs (N= 35), and 0.00625 (i.e.,
0.05/8) for seven subcortical volume plus lateral ventricle AIs (N= 8). This showed
that a difference of roughly Cohen’s d= 0.13 would be detectable with 80% power
in the cortical analyses, and Cohen’s d= 0.12 in the subcortical analyses.
Sensitivity analyses. No outliers were removed for the primary analysis, but to
confirm that results were not dependent on outliers, all analyses were repeated after
having winsorized using a threshold of k= 3, for each AI measure separately. That
is to say, the two highest and two lowest values were assigned the value of the third
highest or lowest value, respectively, separately per AI. This threshold was chosen
after visual inspection of frequency histograms.
The relationships between AIs and age showed no overt non-linearity
(Supplementary Figs. 9–11), so no polynomials for age were incorporated in the
models for primary analysis. However, analyses were repeated using an additional
non-linear term for age, to check whether this choice had affected the results. As
Age and Age2 are highly correlated, we made use of the poly()-function in R for
these two predictors, which created a pair of uncorrelated variables to model age
effects (so-called orthogonal polynomials)76, where one variable was linear and one
non-linear.
As our data included participants as young as 1.5 years of age, and segmentation
of very young brains might be especially challenging for the FreeSurfer algorithms,
we also repeated our primary analysis excluding all individuals aged below 6 years
(N= 64 controls, N= 113 cases), to assess whether they might have impacted the
findings substantially (although these had passed the same quality control
procedures as all other data sets, and FreeSurfer segmentation in preschoolers is
generally of good quality, even before visual QC77).
As adults aged over 40 years were relatively sparsely represented, we also
repeated the primary analysis after removing any individuals aged ≥ 40, in case
modeling of age as a continuous predictor might have been unduly affected by
these individuals. (In addition, see below for further analysis of age, for the
purposes of subset and interaction analyses).
Finally, we repeated the primary analysis using only the subset of 3 T acquired
data (45 out of 54 data sets), to test for possible sensitivity to this technical variable.
The sample was reduced from 1778 cases and 1829 controls in the primary analysis
to 1467 cases and 1574 controls in the 3T-only analysis.
Directions of asymmetry changes. For any AIs showing significant effects of
diagnosis in the primary analysis, linear mixed effects modeling was also performed
on the corresponding L and R measures separately, to understand the unilateral
changes involved. The models included the same terms as were used in the main
analysis of AIs (i.e., diagnosis, age and sex as fixed factors, and data set as random
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factor). Again, the Cohen’s d effect sizes for diagnosis were calculated based on the
t-statistics. The raw mean AI values were calculated separately in controls and
cases, to describe the reference direction of healthy asymmetry in controls, and
whether cases showed reduced, increased, or reversed asymmetry relative to
controls.
Age- or sex-specific effects. For all AIs, we carried out secondary analyses
including age ∗ diagnosis and sex ∗ diagnosis interaction terms, in separate models.
The models were as follows: AI= diagnosis+ age+ sex+ age ∗ diag+ random
(= data set), and AI= diagnosis+ age+ sex+ sex ∗ diag+ random (= data set).
In addition, we separated the data into two subsets by age, i.e., children < 18
years and adults ≥ 18 years (using the same criteria as van Rooij et al. 2018), or else
by sex (males, females). Models were then fitted separately for each AI within each
subset, i.e., within each age subset AI= diagnosis+ sex+ random (= data set), and
within each sex subset AI= diagnosis+ age+ random (= data set).
Analysis of IQ. For each AI that showed a significant effect of diagnosis in the
primary analysis, we carried out exploratory analyses of IQ in cases and controls
separately, whereby IQ (as a continuous variable) was considered as a predictor
variable for the AI, so that AI= IQ+ age+ sex+ random (= data set). This was
done to understand whether individual differences in asymmetry might relate to
IQ, and whether such relations might be specific to ASD.
ADOS severity score. For each AI that showed a significant effect of diagnosis in
the primary analysis, a within-case-only analysis was performed incorporating
symptom severity based on ADOS score as a predictor variable for AI: AI=
ADOS+ age+ sex+ random (= data set). This was to understand whether the
observed asymmetry changes in cases were dependent on ASD severity. ADOS
scores were first adjusted using log10 transformation to reduce skewing.
Analysis of medication use. Data on medication use (i.e., current use of psy-
chiatric treatment drugs prescribed for ASD or comorbid psychiatric conditions)
was available for 832 individuals with ASD, of which 214 were categorized as
medication users. For each AI that showed a significant effect of diagnosis in the
primary analysis, a linear mixed model analysis was performed within-cases only,
AI=medication+ age+ sex+ random (= data set). ‘Medication’ was coded as a
binary variable (0= no medication, 2=medication).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
This study made use of 54 separate data sets collected around the world, under a variety
of different consent procedures and regulatory bodies, during the past 25 years. Requests
to access the data sets will be considered in relation to the relevant consents, rules and
regulations, and can be made via the ENIGMA consortium’s ASD working group http://
enigma.ini.usc.edu/ongoing/enigma-asd-working-group/
Code availability
The R scripts used to generate the results of the current study are included
(Supplementary Software 1).
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